Lexeo Therapeutics (LXEO) Shares Issued (2022 - 2026)
Lexeo Therapeutics (LXEO) posted Shares Issued of $52285.0 for Q1 2026, down 98.81% sequentially from $4.4 million in Q4 2025, and down 19.98% YoY from $65342.0 in Q1 2025.
Lexeo Therapeutics (LXEO) Shares Issued (2022 - 2026) Analysis & Trends
Lexeo Therapeutics has reported Shares Issued for 5 years, with the latest figure at $52285.0 in Q1 2026.
- Quarterly Shares Issued fell 19.98% year-over-year to $52285.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $52285.0 (down 19.98% YoY) and the FY2025 annual result came in at $4.4 million, up 27.15% from the prior year.
- Shares Issued fell to $52285.0 in Q1 2026 per LXEO's latest filing, from $4.4 million in the prior quarter.
- Over five years, Shares Issued peaked at $4.5 million in Q3 2025 and troughed at $52285.0 in Q1 2026.
- A 5-year average of $2.8 million and a median of $3.4 million in 2024 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2024 and 2025: Shares Issued surged 49.47% in 2024, then sank 98.03% in 2025.
- Over 5 years, Shares Issued stood at $1.9 million in 2022, then climbed by 26.07% to $2.4 million in 2023, then jumped by 43.14% to $3.5 million in 2024, then rose by 27.15% to $4.4 million in 2025, then tumbled by 98.81% to $52285.0 in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $52285.0, $4.4 million, and $4.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Lexeo Therapeutics | 397.10 Mn | 397.10 Mn | - | 6.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.47 Mn |
| Jun 30, 2026 | 6.47 Mn |
| Mar 31, 2026 | 52,285.00 |
| Mar 31, 2026 | 52,285.00 |
| Dec 31, 2025 | 4.40 Mn |
| Dec 31, 2025 | 4.40 Mn |
| Sep 30, 2025 | 4.48 Mn |
| Sep 30, 2025 | 4.48 Mn |
| Jun 30, 2025 | 4.40 Mn |
| Jun 30, 2025 | 4.40 Mn |
| Mar 31, 2025 | 65,342.00 |
| Mar 31, 2025 | 65,342.00 |
| Dec 31, 2024 | 3.46 Mn |
| Dec 31, 2024 | 3.46 Mn |
| Sep 30, 2024 | 3.47 Mn |
| Sep 30, 2024 | 3.47 Mn |
| Jun 30, 2024 | 3.46 Mn |
| Jun 30, 2024 | 3.46 Mn |
| Mar 31, 2024 | 3.31 Mn |
| Mar 31, 2024 | 3.31 Mn |